chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever, congestion, cough- developed 103.4 degrees f temperature at time of visit.
ADACEL given in high left shoulder 6-8-09.  (Patient is 65 and should have received plain DT.)  Patient developed general pain & stiffness in left shoulder joint one day later, no clinical evidence of inflammation but marked functional impairment - Rx TRAMADOL & physical therapy
I was hired at a new job, and one of the conditions of employment includes being fully vaccinated against the COVID-19 virus.  I made an appointment and was given the Moderna vaccine injection (primary series) at the above-listed (facility) on April 1st (28 days later) at the same location.  On the day of my appointment (April 1st), 9:30 am) I received a text message canceling my appointment for the 2nd injection, advising that their supply of Moderna was EXPIRED.  After calling numerous pharmacies, I was advised that the Moderna vaccine was unavailable & that they only carried the Pfizer vaccine.  This has resulted in my date to start my new job being pushed back by a full week, and I had already left my previous job.  Per the CDC website, vaccine providers are supposed to check their expiration dates weekly.  This has caused me a great deal of angst, frustration, and hardship.  I pray that something can be done to remedy this issue so that no other patient has to go through the same experience.
Erythema, induration, tenderness right anterolateral thigh, noted by parents 7/23/03, 15 days after injection. Erythema less on 7/24/03, per parents history. Erythema in a ring, 2cm wide, 5cm across, 6cm long. Ill defined edges, blotchy. Central induration, mild tenderness to palpation. No heat, no fever. Well appearing.
Eleven days post vax, pt experienced a high fever of approximately 105F.  The next day the pt developed red lesions on his face and arms. The following day the pt developed additional lesions all over the trunk of his body.
Patient arrived back in office after close to 1 hour  of vaccines administration complaining of  uncontrollable shivering and feeling cold.  vitals were taken and tylenol given,  due to temperature of 38.0C.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 09-JUN-2008, the patient was inoculated with ZOSTAVAX at a family medicine office as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster, also known as shingles and other complications. On or about 02-JUL-2012, the patient was treated at the same family medicine office for a blistering vesicular outbreak that was diagnosed as severe herpes zoster or shingles. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
Hot rash(almost like a sunburn) on my body. Mainly chest and arms., neck, shoulders. A little on back stomach and legs. Started sat jan 30 and is still present.  Also had bodyaches, headache and chills. Those are gone now.
I developed a non-hodkins lymphoma.  Was hospitalized on June 20, 2021 and a biopsy was completed that week.  I have completed 6 months of chemo and immunotherapies.  The cancer was wrapped around the aorta and I was short of breath because of fluid in my lungs as well as lightheaded/dizzy.  Severe pain in my thoracic spine as well. This was six months after my first injection.  Not sure it has any relationship to the vaccine but was recommended by your person who called to submit a report.
Post vax, at 11:10 AM, pt returned to office; coughing/wheezing/itchy and was given Benadryl, 1 tsp. At 11:15, pt was given albuterol per nebulizer; RR-40 with mild retractions. At 11:25, pt was given Epi 1:100, SC, and at 11:28, pt's RR-28, no wheeze and good aeration.
Patient began complaining of left upper lip swelling, shortness of breath and tightness of throat 10 minutes after receiving  second dose of Pfizer vaccine. Epinephrine was administered and patient had a significant resolution of symptoms 6 minutes after administration with reduction in swelling and improvement in breathing. 911 was called and patient was transported to emergency department for further monitoring and evaluation.
This is a spontaneous report from a contactable consumer. A contactable consumer (Patients mother)reported that a 15-year-old male patient received second dose of bnt162b2 (BNT162B2, Solution for injection, lot: EW0178) via unspecified route of administration on 08Jun2021 as single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. the patient previously took first dose of bnt162b2 on an unspecified date for COVID-19 immunization. Reporter stated, her 15 years old had his 2nd Pfizer Vaccine on Tuesday. He has developed a marble size lump above his collar bone, and she don't know whether she need, was it dangerous, a problem, does she need to seek medical attention. she doesn't know how to proceed. Reporter stated, she just wanted to talk to somebody to know whether she need to do something about this reaction please. Outcome of the event was unknown. No follow-up attempts possible. No further information expected. Information on the lot/ batch number has been requested.
Employee was given a Hepatitis B vaccination to her left deltoid. Employee came to the medical staff at the plasma center to report feeling dizzy, light headed, nausea, upset stomach and a head ache. Employee was able to lay down on a medical bed and s/s mostly resolved with only c/o head ache and light headedness.
Pfizer 5 to 11 monovalent was administered as booster dose. Should have been bivalent formulation.
Patient experienced some facial flushing, and stated he throat was a little itchy. Patient had BP repeated periodically. First BP was 215/92 HR 64. Then as follows over the next 40 min. 199/86, 187/85, 144/68, 178/79, 174/79 and 172/79. Patient was given 25 mg oral benadryl. After about 20 min. Patient stated her throat was better but her BP was still elevated and face was still flush.   Patient was transported by wheel chair to ER to be evaluated.
Patient complained of feeling a burning sensation in her throat and ears 30 minutes after receiving the vaccination. The burning sensation subsided within 10 minutes.
Patient received Moderna on 1/8/21 and 2/5/21 at a separate vaccination clinic. Patient received Pfizer 3rd dose on 9/15/21. Nurse vaccinated patient before forms were given to screener and submitted to check-in to be put into system; thus, it was missed that patient received Moderna instead of Pfizer. We informed patient of the mistake and how there currently is no evidence on mixed vaccination series and to look out for signs and symptoms that would require immediate medical attention such as difficulty breathing, wide spread rashes, fainting, chest pain, swelling, etc.
Information was received 30-JUN-2017 via a phone call from a licensed practical nurse who reported that a patient (age and gender not specified) was administered an improperly stored dose of PNEUMOVAX 23 on an unspecified date. Lot number and expiration date were not provided. No adverse effects were reported. No additional information was provided. This is one of several cases from the same reporter. Additional information was requested. Sender's Comments: US-009507513-1707USA005581: US-009507513-1707USA009865: US-009507513-1707USA009866: US-009507513-1707USA009867: US-009507513-1707USA009869.
Pain; muscle pain; tiredness; headache; shivering; fever; This case was reported by a consumer and described the occurrence of pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 22nd October 2019, the patient received Shingrix. In October 2019, less than a week after receiving Shingrix, the patient experienced pain, muscle pain, tiredness, headache, shivering and fever. On an unknown date, the outcome of the pain, muscle pain, tiredness, headache, shivering and fever were unknown.   It was unknown if the reporter considered the pain, muscle pain, tiredness, headache, shivering and fever to be related to Shingrix.  Additional details were provided as follows: This case was reported by the patient. The age at vaccination was not reported. The age group was not reported, but was selected as adult as per vaccine indication. The patient received a Shingrix booster on the day before reporting date and experienced side effects such as pain, muscle pain, tiredness, headache, shivering and fever. The reporter was inquiring about how it would take for them to go away.
12/24/2021 - noticable loss of hair around hairline on forhead January 2022 - quarter size of hairloss on back of head June 2022 - 95% bald
Patient received vaccine after published expiration date. Moderna company analyzed batch/lot# 007B21A and indicated vaccine maintained activity necessary to protect against COVID-19 at time of administration. Patient did not call in to report any adverse event. This is an administration error without adverse event.
At 610 PM received call from stating pt had flu shot today. Went home and took a run. She came back c/o "having a hard time breathing". Mom reported breaking out on neck, back, both arms, both legs, and chest area. Mom instructed to give Benadryl and call 911 if symptoms worsened.
Tickle in throat, cough, throat clearing started approximately 10 minutes after injection. After about 40 minutes of these symptoms , received Benadryl 50 mg po, symptoms continued, tachycardia and tachypnea developed and worsened to near continuous cough, hoarseness/laryngitis, tachypnea, tachycardia, nausea, dry heaves, difficulty swallowing, trouble catching breath over next 30 minutes or so. Received solumedrol 125 mg IV, epinephrine im x2, Pepcid IV, racemic epinephrine neb, epinephrine gtt starting at 0.05 mcg/kg/min. After 2nd IM epinephrine, symptoms slightly improved. After approximately 1h on gtt, was able to be decreased to 0.02 mcg/kg/min and then turned off after another 30-60 min.
Pfizer child 5 to 11-year-old product and dose (0.2mL) given instead of 0.3mL adult product given.
On July 9th participant woke up and notice he was not hearing out of his left ear and he knew something was wrong. In his right ear he could still hear called an ENT to check it out they put him on a steroid to help it. The prescriptions didn't help he went back to the ENT on the 19th they gave him a shot in his ear drum. Stated he has no hearing in his left ear and its still bothering him.
running a fever last night, 18Feb2021 of 101 to 102; This is a spontaneous report from a non-contactable consumer or other non hcp (patient). A female patient of an unspecified age received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number: UNKNOWN), via an unspecified route of administration on 20Jan2021 as dose 2, single for COVID-19 immunisation. The medical history and concomitant medications of the patient were not reported. On 18Feb2021, the patient experienced running a fever last night, 18feb2021 of 101 to 102. The patient wanted to know if that could be a side effect one month post vaccine. This case was reported as non-serious. The patient underwent lab tests and procedures which included fever: 101 to 102 on 18Feb2021. The outcome of the event was reported as unknown.  No follow-up attempts are Possible. Information on lot/batch cannot be obtained.
Phone call from patients mom 11/26/02 morning reporting hard red symmetrical patch on left upper arm 3" in diameter. Patient came to office on 11/27/02-see photo-marked swelling of entire left upper arm. Erythematous, warm, mildly tender.
Blood stain streaks bright red in feces; Nausea; fatigue; Headache; Diarrhoea; Feeling gassy; Fever; Vomiting yellow bile; A spontaneous report was received from a consumer regarding a 63-year-old male patient who received Moderna covid-19 vaccine and have experienced blood stain in faeces, vomiting, nausea, headache, flatulence, fatigue and fever.    The patient's medical history was not provided. His concomitants include Baby aspirin (blood thinner),Potassium(for low potassium),Gabapentin(for pain),VitB12(for nerves),Duloxetine Hcl (Neuropathy),Doxazosin Mesylate ( for prostrate),Lisinopril(for hypertension),Simvastatin(for cholesterol) and Alprazolam(anti-anxiety).No information on allergies.   On 10-FEB-2021, prior to the onset of events, the patient received his first of two planned doses of covid-19 vaccine intramuscularly for the prophylaxis of covid-19 infection (Lot#015M20A). On 11-FEB-2021, he vomited yellow bile looking stuff, had diarrhea, fever and felt gassy. On 12-FEB-2021, he no longer felt vomiting, but felt nauseous, slight fever, fatigue and headache. On 13-FEB-2021, he felt nauseous and had blood stained faeces (bright red). Caller was informed to consult physician for treatment and her question regarding second dose for her husband.  Action taken with 2nd dose of Moderna Covid-19 vaccine was not reported.  The outcome of the event vomiting is recovered, but other events are not recovered at the time of report.; Reporter's Comments: Very limited information regarding this events has been provided at this time.  Further information has been requested.
Extreme fatigue, chills, body aches, aching in joints  - I did not seek treatment as I knew this was considered a possible side effect of second does. I am only reporting for statistical purposes. The symptoms lasted 2 full days.
Patient received 2.5ml dose IM into left arm instead of 0.25ml booster dose.  Patient did not have any immediate adverse reaction.  Patient caregiver reported no adverse reaction 1 hour after administration.  Patient reports no adverse reactions at 4.5 hours post administration.
Subsequent to receiving varicella virus vaccine live, pt experienced a mild breakthrough of chickenpox. Additional information has been requested.
Two seizures of Left arm shaking and non-responsiveness with urinary voiding and post-ictal state the day after vaccination
Migrating Full Body Urticaria for one week beginning around 10 days post Moderna booster. Since then I have managed using 10 mg cetirizine which helps diminish the urticaria/dermatographia. Upon cessation of antihistamine, hives return 2-3 days later.
Patient passed away unrelated to covid vaccine Narrative:  The patient had prostate cancer, Merkle cell carcinoma and clear cell carcinoma of kidney. Patient has been placed on hospice care. Patient received the first dose of Pfizer on 2/1 and no adverse reaction was reported. Patient passed away on 2/5. No indication that death was related to COVID 19 vaccination.
sore arm; chest pain; chills; fever; Headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (sore arm), CHEST PAIN (chest pain), CHILLS (chills), PYREXIA (fever) and HEADACHE (Headache) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 15-Apr-2021, the patient experienced PAIN IN EXTREMITY (sore arm), CHEST PAIN (chest pain), CHILLS (chills), PYREXIA (fever) and HEADACHE (Headache). At the time of the report, PAIN IN EXTREMITY (sore arm), CHEST PAIN (chest pain), CHILLS (chills), PYREXIA (fever) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included Advil. Concomitant medications were not provided.
Bell?s Palsy, right side of face is paralyzed, severe pain around and behind right ear.
Patient developed herpes Zoster shingleo in Nov 2008 Vaccine given 6/17/08
Large area deltoids about 4 x 4 inches right and left erythema, warmth and tenderness.
low grade fever (99.1), arthralgia, chills, malgia, mild headache. started in the night around 1am. Fever started around 6am
POST VACCINE, C/O ITCHING, SCRATCHY THROAT, REQUESTING TO BE MONITORED LONGER TO BE SAFE, ADMITS TO ANXIETY AND FEAR OF NEEDLES. GIVEN COLD WATER AND LAYING ON STRETCHER. VSS THROUGHOUT EPISODE. S/S RESOLVED SPONTANEOUSLY, ESCORTED TO EXIT WITH NO ISSUES AT 1730. 1705 SITTING BP 131/72 HR 88 RR 18 SATS 100% RA 1720 STANDING BP 102/72 HR 90 RR 20 SATS 100% RA
Systemic: Fainting / Unresponsive-Medium, Systemic: Shakiness-Medium, Additional Details: violent shaking for short term, fell towards floor from seat position, father caught before hitting floor. blood pressure checked was in normal limits
Pt received Flu shot and shortly after she had numbness & tingling in the forearm of the same arm. Then it became itchy and a mild rash appeared, Pt also became lightheaded. I monitored pt and within 1/2 hour lightheadedness went away, 50mg BENADRYL took down itch & rash.
Information has been received from an administrative assistant and a medical assistant concerning multiple unspecified patients of unknown age and gender. On unknown dates these patients received GARDASIL (lot#, dose, route not reported) that were improperly stored. Concomitant medications were not provided. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.
vaccine could have contributed to the positive test; her father who received the first dose of the Pfizer-BioNtech Covid-19 vaccine on 27MAR2021 the following week he tested positive for Covid-19.; This is a spontaneous report received from a contactable consumer (patient father) via a medical information team. A 56-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number unknown, Expiration date unknown), via an unspecified route of administration, on 27Mar2021 at single dose for covid-19 Immunization. Medical history and concomitant medication were not reported. It was reported, on behalf of her father who received the first dose of the Pfizer-BioNtech Covid-19 vaccine on 27Mar2021 the following week, on an unspecified date in 2021, he tested positive for Covid-19. They would like to know if there was a time frame when he was able to receive the second dose of the vaccine, he was scheduled 3 weeks after the first dose however they would like to know the "regulation" for this cases and if the vaccine could have contributed to the positive test. The outcome of events was unknown.  Information on batch/lot number requested. Additional information required.
been on the couch; pains; Sick at my stomach; Fever running up down; Aches; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (been on the couch), ABDOMINAL PAIN UPPER (pains), ABDOMINAL DISCOMFORT (Sick at my stomach), PYREXIA (Fever running up down) and MYALGIA (Aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Patient had Covid around March it was not too bad) in March 2021.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jun-2021, the patient experienced ILLNESS (been on the couch), ABDOMINAL PAIN UPPER (pains), ABDOMINAL DISCOMFORT (Sick at my stomach), PYREXIA (Fever running up down) and MYALGIA (Aches). At the time of the report, ILLNESS (been on the couch), ABDOMINAL PAIN UPPER (pains), ABDOMINAL DISCOMFORT (Sick at my stomach), PYREXIA (Fever running up down) and MYALGIA (Aches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Jun-2021, Body temperature: 101 (High) 101.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no relevant concomitant product was reported.  no treatment product was reported
Severe injection site swelling (grapefruit size); Nose bleed; Fever of 102; Lethargy; Tachycardia; Shortness of Breath; Severe joint pain; Migraine; Muscle pain; This is a spontaneous report from a contactable other healthcare professional (HCP reporting for self). A 26-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, lot number and expiry date not reported), via an unspecified route of administration on 27Jan2021 11:30 at a single dose in the right arm for COVID-19 immunization. Other medical history and known allergies were reported as none. The patient had no COVID prior vaccination. The patient was not pregnant at the time of the report and vaccination. Concomitant medications included zinc, ascorbic acid (VIT C), ergocalciferol (VIT D) and an unspecified birth control medication. The first dose of BNT162B2 (brand: Pfizer as reported) was received on 06Jan2021 12:00 PM in the left arm for COVID-19 immunization.  The patient had no other vaccine in the four weeks prior to second dose vaccination. On 27Jan2021 23:00, the patient experienced nose bleed, fever of 102, severe injection site swelling (grapefruit size), lethargy, tachycardia, shortness of breath, severe joint pain, migraine and muscle pain. The patient did not receive treatments for the reported adverse events. Patient had COVID test post vaccination specified as nasal swab on 27Jan2021 with test result as negative. The events were reported as recovered with lasting effects.   Information on the Lot/Batch number has been requested.; Sender's Comments: Considering the close drug-event temporal association and the location,  the reasonable possibility that the reported severe injection site swelling is related to BNT162B2 seems likely.
Pain, severe swelling, muscle pain (could not move arm), headache, chills and shivering, upset stomach and extreme tiredness. I know these are common symptoms, but since I had almost all for 54 hours, I thought I should report them.
Pt reported she developed a fever and what felt like an "out of body experience" after the 3rd dose of Imovax.
Patient reported symptoms ~ 2mins after receiving vaccine per administering clinician. Patient noted to have coughing. Patient reported lip numbness and mild shortness of breath. Patient then continued to say that she was having difficulty swallowing.  EMS was contacted. Patient awake, alert, oriented. Patient refused EPI administration at vaccine site.   Patient taken by EMS to ED. Per medical record patient received IV antihistamines and steroids and was observed.
Vaccine administered 9/30/10. Patient returned to pharmacy 16:15 with generalized swelling, redness on entire upper arm from shoulder to elbow, swelling and red and hot. Treated with Cephalexin for one week and now fine. Follow up done. MD felt pt had local swelling, inflammation and infection. Now resolved without lasting effects.